Nieves-Cintrón Madeline, Nystoriak Matthew A, Prada Maria Paz, Johnson Kenneth, Fayer William, Dell'Acqua Mark L, Scott John D, Navedo Manuel F
From the Department of Pharmacology, University of California, Davis, California 95616.
the Department of Pharmacology, University of Colorado, Denver, Colorado 80045, and.
J Biol Chem. 2015 Mar 20;290(12):7918-29. doi: 10.1074/jbc.M114.622811. Epub 2015 Feb 10.
Enhanced arterial tone is a leading cause of vascular complications during diabetes. Voltage-gated K(+) (KV) channels are key regulators of vascular smooth muscle cells (VSMCs) contractility and arterial tone. Whether impaired KV channel function contributes to enhance arterial tone during diabetes is unclear. Here, we demonstrate a reduction in KV-mediated currents (IKv) in VSMCs from a high fat diet (HFD) mouse model of type 2 diabetes. In particular, IKv sensitive to stromatoxin (ScTx), a potent KV2 blocker, were selectively reduced in diabetic VSMCs. This was associated with decreased KV2-mediated regulation of arterial tone and suppression of the KV2.1 subunit mRNA and protein in VSMCs/arteries isolated from HFD mice. We identified protein kinase A anchoring protein 150 (AKAP150), via targeting of the phosphatase calcineurin (CaN), and the transcription factor nuclear factor of activated T-cells c3 (NFATc3) as required determinants of KV2.1 suppression during diabetes. Interestingly, substantial reduction in transcript levels for KV2.1 preceded down-regulation of large conductance Ca(2+)-activated K(+) (BKCa) channel β1 subunits, which are ultimately suppressed in chronic hyperglycemia to a similar extent. Together, our study supports the concept that transcriptional suppression of KV2.1 by activation of the AKAP150-CaN/NFATc3 signaling axis contributes to enhanced arterial tone during diabetes.
动脉张力增强是糖尿病期间血管并发症的主要原因。电压门控钾离子(KV)通道是血管平滑肌细胞(VSMC)收缩性和动脉张力的关键调节因子。目前尚不清楚KV通道功能受损是否会导致糖尿病期间动脉张力增强。在此,我们证明了在2型糖尿病的高脂肪饮食(HFD)小鼠模型的VSMC中,KV介导的电流(IKv)减少。特别是,对强效KV2阻滞剂基质毒素(ScTx)敏感的IKv在糖尿病VSMC中选择性降低。这与KV2介导的动脉张力调节降低以及从HFD小鼠分离的VSMC/动脉中KV2.1亚基mRNA和蛋白质的抑制有关。我们确定蛋白激酶A锚定蛋白150(AKAP150)通过靶向磷酸酶钙调神经磷酸酶(CaN)和活化T细胞的转录因子核因子c3(NFATc3)是糖尿病期间KV2.1抑制的必需决定因素。有趣的是,KV2.1转录水平的大幅降低先于大电导钙激活钾离子(BKCa)通道β1亚基的下调,而BKCa通道β1亚基最终在慢性高血糖症中受到类似程度的抑制。总之,我们的研究支持这样一个概念,即通过激活AKAP150-CaN/NFATc3信号轴对KV2.1进行转录抑制有助于糖尿病期间动脉张力增强。